Christina Lönnroth

Title: Christina Lönnroth: Innovator in Antisecretory Factor Peptides

Introduction

Christina Lönnroth is a notable inventor based in Mölndal, Sweden. She has made significant contributions to the field of biomedical research, particularly in the development of innovative peptides that regulate pathological permeability changes. Her work has the potential to impact both veterinary and human medicine.

Latest Patents

Christina Lönnroth holds a patent for a groundbreaking invention titled "Antisecretory factor peptides regulating pathological permeability changes." This patent describes a new recombinant protein known as Antisecretory Factor (rAF) and its homologues and peptide fragments. The rAF protein and its derivatives are designed to normalize pathological fluid transport and inflammatory reactions in both animals and humans. The patent also covers antibodies against AF or its homologues and fragments, as well as nucleic acids coding for the protein. These innovations could be utilized for immunodetection, as feed additives for growing animals, and as antidiarrheal drugs for conditions involving edema, dehydration, and inflammation.

Career Highlights

Christina Lönnroth is associated with Rural Patent Svenska AB, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving health outcomes through innovative solutions in peptide technology.

Collaborations

Some of her notable coworkers include Ivar Lönnroth and Stefan Lange, who contribute to her research endeavors and collaborative projects.

Conclusion

Christina Lönnroth's contributions to the field of biomedical research through her innovative peptides highlight her role as a leading inventor. Her patent on Antisecretory Factor peptides showcases her dedication to addressing critical health challenges.